Journals / Pamukkale Tıp Dergisi / 2020 / Cilt: 13 - Sayı: 3

Primary central nervous system lymphomas: retrospective analysis of 10 cases.

Primer santral sinir sistemi lenfomaları: 10 vakanın retrospektif analizi.

Pages
605–611
Publication Date
2020-09-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Diffuse large B-cell lymphoma is the most common subtype and basal ganglia is the most common site.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: Primary central nervous system (CNS) lymphoma, a rare form of non-Hodgkin's lymphoma (NHL), is defined as high-grade B cell neoplasm of aggressive extranodal CNS.
📊
Key Findings & Data:Materials and methods: Between May 2011 and January 2017, 10 patients with pathologic confirmation of primary CNS lymphoma were retrospectively reviewed.
💡
Conclusion & Impact:Diffuse large B-cell lymphoma is the most common subtype and basal ganglia is the most common site.
🔬Design:Review & Systematic Survey
📍Scope:2011 Verileri
⚙️Variables:Non-Hodgkin lenfoma · santral sinir sistemi · primer lenfoma

Abstract

Purpose: Primary central nervous system (CNS) lymphoma, a rare form of non-Hodgkin's lymphoma (NHL), is defined as high-grade B cell neoplasm of aggressive extranodal CNS. The incidence of CNS lymphoma has been increasing in recent years. In general, it has a poor prognosis. The aim of this study is to evaluate the clinical, pathological, immunohistochemical and radiological features of patients with primary CNS lymphoma in the light of literature. Materials and methods: Between May 2011 and January 2017, 10 patients with pathologic confirmation of primary CNS lymphoma were retrospectively reviewed. Results: Of 10 patients with CNS lymphoma, 7 (70%) were female and 3 (30%) were male. The mean age of all patients at diagnosis was 59.1±13.98 years. The most common settlements; eight patients (80%) had basal ganglia and 3 patients (30%) had multiple intracranial masses. Sterotaxic brain biopsy was performed in 8 patients (80%) and tumor resection was performed by craniotomy in 2 patients (20%). All of the patients with non-Hodgkin B cell lymphoma had diffuse large B cell lymphoma in 10 (100%). All cases had diffuse and strong positivity for CD20. None of the patients had immunodeficiency. Conclusion: Primary CNS lymphoma with a poor prognosis is frequently seen over 55 years of age. Diffuse large B-cell lymphoma is the most common subtype and basal ganglia is the most common site.

Özet

Amaç: Non-Hodgkin lenfoma (NHL)’ nın nadir bir formu olan primer santral sinir sistemi (SSS) lenfoması, agresif ekstranodal SSS’nin yüksek gradlı B hücre neoplazmı olarak tanımlanır. SSS lenfoma insidansı son yıllarda giderek artmaktadır. Genel olarak kötü prognoza sahiptir. Bu çalışmada; primer SSS lenfoması tanısı alan hastaların klinik, patolojik, immünhistokimyasal ve radyolojik özellikleri literatür eşliğinde değerlendirmesi amaçlanmıştır. Gereç ve yöntem: Mayıs 2011 ile Ocak 2017 tarihleri arasında primer SSS lenfoma tanısı patolojik olarak doğrulanmış 10 hasta retrospektif olarak incelendi. Bulgular: SSS lenfomalı 10 hastanın 7 (%70)’si kadın 3 (%30)’ü erkekti. Tüm hastaların tanı konulduğundaki ortalama yaşları 59,1±13,98 idi. En sık yerleşim yeri; 8 hastada (%80) bazal ganglia bölgesi olup, 3 hastanın (%30) çoklu intrakranyal kitleleri vardı. 8 hastada (%80) sterotaksik beyin biyopsisi, 2 hastada (%20) kranyotomi le tümör rezeksiyonu yapıldı. Tümü non-Hodgkin B hücreli lenfoma olan hastaların 10’u da (%100) diffüz büyük B hücreli lenfoma idi. Tüm vakalarda CD20 için diffüz ve kuvvetli pozitiflik görüldü. İmmün yetmezlik hiçbir hastada yoktu. Sonuç: Kötü prognoza sahip olan primer SSS lenfoması sıklıkla 55 yaşın üzerinde görülür. Diffüz büyük B-hücreli lenfoma en sık alt tip olup bazal ganglia bölgesi en sık yerleşim yeridir.

🔖

Cite This Article

ÖZDEMİR, A., CANAZ, G., TAÇYILDIZ, A., UYSAL, M., OVALIOĞLU, T. (2020). Primary central nervous system lymphomas: retrospective analysis of 10 cases.. Pamukkale Tıp Dergisi, Cilt: 13 - Sayı: 3, 605–611. https://ajindex.com/articles/696469

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Wang CC, Carnevale J, Rubenstein JL. Progress in central nervous system lymphomas. British journal of haematology. 2014 Aug
  2. 166(3):311-25. DOI: 10.1111/bjh.12938 2. Bhagavathi S, Wilson JD. Primary central nervous system lymphoma. Archives of pathology & laboratory medicine. 2008 Nov
  3. 132(11):1830-4. DOI: 10.1043/1543-2165-132.11.1830 3. Brastianos PK, Batchelor TT. Primary central nervous system lymphoma: overview of current treatment strategies. Hematology/oncology clinics of North America. 2012 Aug
  4. 26(4):897-916. DOI: 10.1016/j.hoc.2012.05.003 4. Haque S, Law M, Abrey LE, Young RJ. Imaging of lymphoma of the central nervous system, spine, and orbit. Radiologic clinics of North America. 2008 Mar
  5. 46(2):339-61, ix. DOI: 10.1016/j.rcl.2008.04.003 5. Nayak L, Batchelor TT. Recent advances in treatment of primary central nervous system lymphoma. Current treatment options in oncology. 2013 Dec
  6. 14(4):539-52. DOI: 10.1007/s11864-013-0252-6 6. Perini GF, Campregher PV, Santos FP, Hamerschlak N. Primary central nervous system lymphoma: what a neurologist/neurosurgeon should know? Arquivos de neuro-psiquiatria. 2013 Apr
  7. 71(4):254-7. DOI: 10.1590/0004-282x20130011 7. Phillips EH, Fox CP, Cwynarski K. Primary CNS lymphoma. Current hematologic malignancy reports. 2014 Sep
  8. 9(3):243-53. DOI: 10.1007/s11899-014-0217-2 8. Rubenstein J, Ferreri AJ, Pittaluga S. Primary lymphoma of the central nervous system: epidemiology, pathology and current approaches to diagnosis, prognosis and treatment. Leukemia & lymphoma. 2008
  9. 49 Suppl 1:43-51. DOI: 10.1080/10428190802311441 9. Yoon JH, Kang HJ, Kim H, Lee JW, Park JD, Park KD, et al. Successful treatment of primary central nervous system lymphoma without irradiation in children: single center experience. Journal of Korean medical science. 2012 Nov
  10. 27(11):1378-84. DOI: 10.3346/jkms.2012.27.11.1378 10. Gallop-Evans E. Primary central nervous system lymphoma. Clinical oncology. 2012 Jun
  11. 24(5):329-38. DOI: 10.1016/j.clon.2012.02.009 11. Liu HL, Liu T, Ma C, Zhao Y, Zhou Y. [Clinical characteristics and prognosis of 20 cases of primary central nervous system lymphoma]. Zhongguo shi yan xue ye xue za zhi. 2015 Feb
  12. 23(1):111-8. DOI: 10.7534/j.issn.1009-2137.2015.01.021 12. Bathla G, Hegde A. Lymphomatous involvement of the central nervous system. Clinical radiology. 2016 Jun
  13. 71(6):602-9. DOI: 10.1016/j.crad.2016.02.006 13. Olson JE, Janney CA, Rao RD, Cerhan JR, Kurtin PJ, Schiff D, et al. The continuing increase in the incidence of pr